Cervus elaphus chromosome 16, mCerEla1.1, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Laurasiatheria; Artiodactyla; Ruminantia; Pecora; Cervidae; Cervinae; Cervus.
REFSEQ INFORMATION: The reference sequence is identical to\nOU343093.1.\nAssembly name: mCerEla1.1\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the WELLCOME SANGER INSTITUTE on\n2021/07/07. The original whole-genome shotgun project has the\naccession CAJVBL000000000.1.\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Cervus elaphus Annotation Release\n 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 72% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00003
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 ESTs, and 83% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
family with sequence similarity 110 member C
COORDINATES: polyA evidence [ECO:0006239]
uncharacterized LOC122672993, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC122672993, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
SH3 and SYLF domain containing 1, transcript variant X3
SH3 and SYLF domain containing 1, transcript variant X1
SH3 and SYLF domain containing 1, transcript variant X2
SH3 and SYLF domain containing 1, transcript variant X4
SH3 domain-containing YSC84-like protein 1 isoform X3
SH3 domain-containing YSC84-like protein 1 isoform X1
SH3 domain-containing YSC84-like protein 1 isoform X2
SH3 domain-containing YSC84-like protein 1 isoform X4
SH3 and SYLF domain containing 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 3 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
acid phosphatase 1, transcript variant X3
acid phosphatase 1, transcript variant X5
acid phosphatase 1, transcript variant X6
acid phosphatase 1, transcript variant X1
acid phosphatase 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 93% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
acid phosphatase 1, transcript variant X2
low molecular weight phosphotyrosine protein phosphatase isoform X3
low molecular weight phosphotyrosine protein phosphatase isoform X1
low molecular weight phosphotyrosine protein phosphatase isoform X4
low molecular weight phosphotyrosine protein phosphatase isoform X2
uncharacterized LOC122710262, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC122710262, transcript variant X1
uncharacterized LOC122710262, transcript variant X3
transmembrane protein 18, transcript variant X1
transmembrane protein 18, transcript variant X2
syntrophin gamma 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 ESTs, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
syntrophin gamma 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
syntrophin gamma 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
syntrophin gamma 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
thyroid peroxidase, transcript variant X1
thyroid peroxidase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
myelin transcription factor 1 like, transcript variant X21
myelin transcription factor 1 like, transcript variant X14
myelin transcription factor 1 like, transcript variant X12
myelin transcription factor 1 like, transcript variant X24
myelin transcription factor 1 like, transcript variant X25
myelin transcription factor 1 like, transcript variant X2
myelin transcription factor 1 like, transcript variant X9
myelin transcription factor 1 like, transcript variant X11
myelin transcription factor 1 like, transcript variant X7
myelin transcription factor 1 like, transcript variant X10
myelin transcription factor 1 like, transcript variant X6
myelin transcription factor 1 like, transcript variant X3
myelin transcription factor 1 like, transcript variant X5
myelin transcription factor 1 like, transcript variant X8
myelin transcription factor 1 like, transcript variant X1
myelin transcription factor 1 like, transcript variant X4
myelin transcription factor 1 like, transcript variant X17
myelin transcription factor 1 like, transcript variant X16
myelin transcription factor 1 like, transcript variant X15
myelin transcription factor 1 like, transcript variant X20
myelin transcription factor 1 like, transcript variant X13
myelin transcription factor 1 like, transcript variant X18
myelin transcription factor 1 like, transcript variant X19
myelin transcription factor 1-like protein isoform X12
myelin transcription factor 1-like protein isoform X17
myelin transcription factor 1-like protein isoform X2
myelin transcription factor 1-like protein isoform X9
myelin transcription factor 1-like protein isoform X11
myelin transcription factor 1-like protein isoform X7
myelin transcription factor 1-like protein isoform X10
myelin transcription factor 1-like protein isoform X6
myelin transcription factor 1-like protein isoform X3
myelin transcription factor 1-like protein isoform X8
myelin transcription factor 1-like protein isoform X1
myelin transcription factor 1-like protein isoform X13
myelin transcription factor 1-like protein isoform X16
myelin transcription factor 1-like protein isoform X5
myelin transcription factor 1-like protein isoform X4
myelin transcription factor 1 like, transcript variant X23
myelin transcription factor 1 like, transcript variant X22
myelin transcription factor 1-like protein isoform X15
myelin transcription factor 1-like protein isoform X14
EARP complex and GARP complex interacting protein 1, transcript variant X1
EARP complex and GARP complex interacting protein 1, transcript variant X3
EARP complex and GARP complex interacting protein 1, transcript variant X4
EARP complex and GARP complex interacting protein 1, transcript variant X2
EARP and GARP complex-interacting protein 1 isoform X1
EARP and GARP complex-interacting protein 1 isoform X2
EARP and GARP complex-interacting protein 1 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 29 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
trafficking protein particle complex subunit 12, transcript variant X1
trafficking protein particle complex subunit 12, transcript variant X2
trafficking protein particle complex subunit 12, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
trafficking protein particle complex subunit 12 isoform X1
trafficking protein particle complex subunit 12 isoform X2
trafficking protein particle complex subunit 12 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 97% coverage of the annotated genomic feature by RNAseq alignments
1,2-dihydroxy-3-keto-5-methylthiopentene dioxygenase
uncharacterized LOC122710255, transcript variant X1
uncharacterized LOC122710255, transcript variant X2
doublecortin domain-containing protein 2C
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA arginine (anticodon ACG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 11 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 13 ESTs, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 4% coverage of the annotated genomic feature by RNAseq alignments
COORDINATES: nucleotide motif:Rfam:12.0:RF00026
TNF receptor associated factor 1, transcript variant X8
TNF receptor associated factor 1, transcript variant X3
TNF receptor associated factor 1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
TNF receptor associated factor 1, transcript variant X1
TNF receptor associated factor 1, transcript variant X6
TNF receptor associated factor 1, transcript variant X4
TNF receptor associated factor 1, transcript variant X2
TNF receptor associated factor 1, transcript variant X5
TNF receptor-associated factor 1 isoform X1
TNF receptor-associated factor 1 isoform X2
TNF receptor-associated factor 1 isoform X3
uncharacterized LOC122710152, transcript variant X1
uncharacterized LOC122710152, transcript variant X2
PHD finger protein 19, transcript variant X2
PHD finger protein 19, transcript variant X1
protein CutA homolog, transcript variant X2
protein CutA homolog, transcript variant X1
26S proteasome non-ATPase regulatory subunit 5
beta-1,3-galactosyltransferase 9, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
beta-1,3-galactosyltransferase 9, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
F-box and WD repeat domain containing 2, transcript variant X1
F-box and WD repeat domain containing 2, transcript variant X2
F-box and WD repeat domain containing 2, transcript variant X4
F-box and WD repeat domain containing 2, transcript variant X3
F-box/WD repeat-containing protein 2 isoform X3
F-box/WD repeat-containing protein 2 isoform X1
F-box/WD repeat-containing protein 2 isoform X2
F-box/WD repeat-containing protein 2 isoform X4
beta-1,3-galactosyltransferase 9, transcript variant X4
beta-1,3-galactosyltransferase 9, transcript variant X5
beta-1,3-galactosyltransferase 9, transcript variant X3
multiple epidermal growth factor-like domains protein 9
CDK5 regulatory subunit associated protein 2, transcript variant X3
CDK5 regulatory subunit associated protein 2, transcript variant X1
CDK5 regulatory subunit associated protein 2, transcript variant X8
CDK5 regulatory subunit associated protein 2, transcript variant X7
CDK5 regulatory subunit associated protein 2, transcript variant X6
CDK5 regulatory subunit associated protein 2, transcript variant X5
CDK5 regulatory subunit associated protein 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 39 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
CDK5 regulatory subunit associated protein 2, transcript variant X2
CDK5 regulatory subunit-associated protein 2 isoform X1
CDK5 regulatory subunit-associated protein 2 isoform X7
CDK5 regulatory subunit-associated protein 2 isoform X6
CDK5 regulatory subunit-associated protein 2 isoform X5
CDK5 regulatory subunit-associated protein 2 isoform X3
CDK5 regulatory subunit-associated protein 2 isoform X8
CDK5 regulatory subunit-associated protein 2 isoform X4
CDK5 regulatory subunit-associated protein 2 isoform X2
transfer RNA phenylalanine (anticodon GAA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
BMP/retinoic acid inducible neural specific 1
BMP/retinoic acid-inducible neural-specific protein 1
COORDINATES: nucleotide motif:Rfam:12.0:RF00001
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
tripartite motif containing 32, transcript variant X3
tripartite motif containing 32, transcript variant X7
tripartite motif containing 32, transcript variant X5
tripartite motif containing 32, transcript variant X8
tripartite motif containing 32, transcript variant X2
tripartite motif containing 32, transcript variant X6
tripartite motif containing 32, transcript variant X1
tripartite motif containing 32, transcript variant X10
tripartite motif containing 32, transcript variant X9
tripartite motif containing 32, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 36% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122709998, transcript variant X4
uncharacterized LOC122709998, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC122709998, transcript variant X2
uncharacterized LOC122709998, transcript variant X3
uncharacterized LOC122709998, transcript variant X1
tumor necrosis factor ligand superfamily member 8
tumor necrosis factor ligand superfamily member 15
COORDINATES: nucleotide motif:Rfam:12.0:RF00283
endogenous retrovirus group PABLB member 1 Env polyprotein-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
COORDINATES: nucleotide motif:Rfam:12.0:RF00614
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 1 Protein, and 38% coverage of the annotated genomic feature by RNAseq alignments
transmembrane protein 268, transcript variant X1
transmembrane protein 268, transcript variant X2
transmembrane protein 268, transcript variant X3
transmembrane protein 268, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 66% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 4 ESTs, 9 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 ESTs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
AT-hook transcription factor, transcript variant X4
AT-hook transcription factor, transcript variant X3
AT-hook transcription factor, transcript variant X2
AT-hook transcription factor, transcript variant X1
AT-hook transcription factor, transcript variant X5
microtubule organization protein AKNA isoform X1
microtubule organization protein AKNA isoform X2
collagen type XXVII alpha 1 chain, transcript variant X5
collagen type XXVII alpha 1 chain, transcript variant X6
collagen type XXVII alpha 1 chain, transcript variant X3
collagen type XXVII alpha 1 chain, transcript variant X1
collagen type XXVII alpha 1 chain, transcript variant X2
collagen type XXVII alpha 1 chain, transcript variant X4
collagen alpha-1(XXVII) chain isoform X5
collagen alpha-1(XXVII) chain isoform X6
collagen alpha-1(XXVII) chain isoform X1
collagen alpha-1(XXVII) chain isoform X3
collagen alpha-1(XXVII) chain isoform X2
collagen alpha-1(XXVII) chain isoform X4
collagen type XXVII alpha 1 chain, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
kinesin family member 12, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
kinesin family member 12, transcript variant X2
kinesin family member 12, transcript variant X1
kinesin family member 12, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
kinesin family member 12, transcript variant X5
kinesin family member 12, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
zinc finger protein 618, transcript variant X7
zinc finger protein 618, transcript variant X3
zinc finger protein 618, transcript variant X18
zinc finger protein 618, transcript variant X16
zinc finger protein 618, transcript variant X15
zinc finger protein 618, transcript variant X8
zinc finger protein 618, transcript variant X6
zinc finger protein 618, transcript variant X17
zinc finger protein 618, transcript variant X14
zinc finger protein 618, transcript variant X12
zinc finger protein 618, transcript variant X13
zinc finger protein 618, transcript variant X11
zinc finger protein 618, transcript variant X5
zinc finger protein 618, transcript variant X2
zinc finger protein 618, transcript variant X4
zinc finger protein 618, transcript variant X1
zinc finger protein 618, transcript variant X9
zinc finger protein 618, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 27 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
regulator of G protein signaling 3, transcript variant X1
regulator of G protein signaling 3, transcript variant X2
regulator of G protein signaling 3, transcript variant X3
regulator of G protein signaling 3, transcript variant X8
regulator of G protein signaling 3, transcript variant X6
regulator of G protein signaling 3, transcript variant X5
regulator of G protein signaling 3, transcript variant X7
regulator of G protein signaling 3, transcript variant X11
regulator of G protein signaling 3, transcript variant X10
regulator of G-protein signaling 3 isoform X1
regulator of G-protein signaling 3 isoform X3
regulator of G-protein signaling 3 isoform X2
regulator of G-protein signaling 3 isoform X5
regulator of G-protein signaling 3 isoform X7
regulator of G-protein signaling 3 isoform X8
regulator of G protein signaling 3, transcript variant X4
regulator of G protein signaling 3, transcript variant X9
regulator of G-protein signaling 3 isoform X4
regulator of G-protein signaling 3 isoform X6
chromosome 16 C9orf43 homolog, transcript variant X4
chromosome 16 C9orf43 homolog, transcript variant X5
chromosome 16 C9orf43 homolog, transcript variant X1
chromosome 16 C9orf43 homolog, transcript variant X2
chromosome 16 C9orf43 homolog, transcript variant X3
uncharacterized protein C9orf43 homolog isoform X3
uncharacterized protein C9orf43 homolog isoform X2
uncharacterized protein C9orf43 homolog isoform X1
chromosome 16 C9orf43 homolog, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized protein C9orf43 homolog isoform X4
DNA polymerase epsilon 3, accessory subunit
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
aminolevulinate dehydratase, transcript variant X1
aminolevulinate dehydratase, transcript variant X2
aminolevulinate dehydratase, transcript variant X3
haloacid dehalogenase like hydrolase domain containing 3, transcript variant X1
haloacid dehalogenase like hydrolase domain containing 3, transcript variant X2
haloacid dehalogenase-like hydrolase domain-containing protein 3
B-box and SPRY domain containing, transcript variant X2
B-box and SPRY domain containing, transcript variant X1
B box and SPRY domain-containing protein isoform X2
B box and SPRY domain-containing protein isoform X1
WD repeat domain 31, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
WD repeat domain 31, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
WD repeat domain 31, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
WD repeat-containing protein 31 isoform X1
WD repeat-containing protein 31 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
ring finger protein 183, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 ESTs, 2 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
ring finger protein 183, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 87% coverage of the annotated genomic feature by RNAseq alignments
pre-mRNA processing factor 4, transcript variant X3
pre-mRNA processing factor 4, transcript variant X4
pre-mRNA processing factor 4, transcript variant X2
pre-mRNA processing factor 4, transcript variant X1
pre-mRNA processing factor 4, transcript variant X5
U4/U6 small nuclear ribonucleoprotein Prp4 isoform X4
U4/U6 small nuclear ribonucleoprotein Prp4 isoform X3
U4/U6 small nuclear ribonucleoprotein Prp4 isoform X2
U4/U6 small nuclear ribonucleoprotein Prp4 isoform X1
U4/U6 small nuclear ribonucleoprotein Prp4 isoform X5
cell division cycle 26, transcript variant X1
cell division cycle 26, transcript variant X2
anaphase-promoting complex subunit CDC26 isoform X1
anaphase-promoting complex subunit CDC26 isoform X2
solute carrier family 31 member 1, transcript variant X1
solute carrier family 31 member 1, transcript variant X4
solute carrier family 31 member 1, transcript variant X2
solute carrier family 31 member 1, transcript variant X3
FKBP prolyl isomerase family member 15, transcript variant X5
FKBP prolyl isomerase family member 15, transcript variant X2
FKBP prolyl isomerase family member 15, transcript variant X1
FKBP prolyl isomerase family member 15, transcript variant X3
FKBP prolyl isomerase family member 15, transcript variant X4
FKBP prolyl isomerase family member 15, transcript variant X6
solute carrier family 31 member 2, transcript variant X2
solute carrier family 31 member 2, transcript variant X1
probable low affinity copper uptake protein 2 isoform X1
probable low affinity copper uptake protein 2 isoform X2
A-kinase anchor protein 10, mitochondrial-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 2 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 2 codons; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: A-kinase anchor protein 10, mitochondrial-like
sorting nexin family member 30, transcript variant X1
sorting nexin family member 30, transcript variant X2
transfer RNA glycine (anticodon UCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
KIAA1958 ortholog, transcript variant X7
KIAA1958 ortholog, transcript variant X10
uncharacterized protein KIAA1958 homolog isoform X2
uncharacterized protein KIAA1958 homolog isoform X5
KIAA1958 ortholog, transcript variant X8
uncharacterized protein KIAA1958 homolog isoform X3
KIAA1958 ortholog, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized protein KIAA1958 homolog isoform X4
KIAA1958 ortholog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
KIAA1958 ortholog, transcript variant X1
KIAA1958 ortholog, transcript variant X3
KIAA1958 ortholog, transcript variant X4
KIAA1958 ortholog, transcript variant X5
KIAA1958 ortholog, transcript variant X6
uncharacterized protein KIAA1958 homolog isoform X1
hydroxysteroid dehydrogenase-like protein 2
polypyrimidine tract binding protein 3, transcript variant X1
polypyrimidine tract binding protein 3, transcript variant X2
polypyrimidine tract binding protein 3, transcript variant X4
polypyrimidine tract binding protein 3, transcript variant X5
polypyrimidine tract binding protein 3, transcript variant X3
polypyrimidine tract-binding protein 3 isoform X1
polypyrimidine tract-binding protein 3 isoform X2
polypyrimidine tract binding protein 3, transcript variant X6
polypyrimidine tract-binding protein 3 isoform X3
polypyrimidine tract-binding protein 3 isoform X4
polypyrimidine tract-binding protein 3 isoform X5
polypyrimidine tract binding protein 3, transcript variant X7
polypyrimidine tract-binding protein 3 isoform X7
polypyrimidine tract-binding protein 3 isoform X6
COORDINATES: nucleotide motif:Rfam:12.0:RF00020
uncharacterized LOC122710264, transcript variant X2
uncharacterized LOC122710264, transcript variant X1
sushi domain containing 1, transcript variant X3
sushi domain containing 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
sushi domain containing 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
sushi domain-containing protein 1 isoform X2
sushi domain-containing protein 1 isoform X1
sushi domain-containing protein 1 isoform X3
UDP-glucose ceramide glucosyltransferase
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 36% coverage of the annotated genomic feature by RNAseq alignments
protein shortage in chiasmata 1 ortholog
uncharacterized LOC122673017, transcript variant X2
uncharacterized LOC122673017, transcript variant X1
G protein subunit gamma 10, transcript variant X1
G protein subunit gamma 10, transcript variant X2
guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10
DnaJ heat shock protein family (Hsp40) member C25
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 49% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins
Ecm29 proteasome adaptor and scaffold, transcript variant X4
Ecm29 proteasome adaptor and scaffold, transcript variant X3
proteasome adapter and scaffold protein ECM29 isoform X3
Ecm29 proteasome adaptor and scaffold, transcript variant X1
Ecm29 proteasome adaptor and scaffold, transcript variant X2
proteasome adapter and scaffold protein ECM29 isoform X1
proteasome adapter and scaffold protein ECM29 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 27 Proteins
COORDINATES: nucleotide motif:Rfam:12.0:RF00004
lysophosphatidic acid receptor 1, transcript variant X1
lysophosphatidic acid receptor 1, transcript variant X2
muscle associated receptor tyrosine kinase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 ESTs, 3 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
muscle associated receptor tyrosine kinase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 ESTs, 3 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
muscle, skeletal receptor tyrosine-protein kinase isoform X2
muscle, skeletal receptor tyrosine-protein kinase isoform X1
sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1
sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1
thioredoxin domain containing 8, transcript variant X2
thioredoxin domain containing 8, transcript variant X1
thioredoxin domain-containing protein 8 isoform X2
thioredoxin domain-containing protein 8 isoform X1
uncharacterized protein C9orf152 homolog
PALM2 and AKAP2 fusion, transcript variant X4
PALM2 and AKAP2 fusion, transcript variant X3
PALM2 and AKAP2 fusion, transcript variant X2
PALM2 and AKAP2 fusion, transcript variant X5
PALM2 and AKAP2 fusion, transcript variant X1
PALM2 and AKAP2 fusion, transcript variant X8
PALM2 and AKAP2 fusion, transcript variant X7
PALM2 and AKAP2 fusion, transcript variant X6
PALM2 and AKAP2 fusion, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins
signal peptidase complex catalytic subunit SEC11A-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 3 ESTs, 29 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
protein tyrosine phosphatase non-receptor type 3, transcript variant X1
tyrosine-protein phosphatase non-receptor type 3 isoform X1
protein tyrosine phosphatase non-receptor type 3, transcript variant X3
protein tyrosine phosphatase non-receptor type 3, transcript variant X2
tyrosine-protein phosphatase non-receptor type 3 isoform X2
protein tyrosine phosphatase non-receptor type 3, transcript variant X4
tyrosine-protein phosphatase non-receptor type 3 isoform X3
erythrocyte membrane protein band 4.1 like 4B, transcript variant X1
erythrocyte membrane protein band 4.1 like 4B, transcript variant X4
erythrocyte membrane protein band 4.1 like 4B, transcript variant X6
erythrocyte membrane protein band 4.1 like 4B, transcript variant X3
erythrocyte membrane protein band 4.1 like 4B, transcript variant X2
erythrocyte membrane protein band 4.1 like 4B, transcript variant X7
erythrocyte membrane protein band 4.1 like 4B, transcript variant X5
erythrocyte membrane protein band 4.1 like 4B, transcript variant X8
ATP synthase subunit ATP5MJ, mitochondrial-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 56% coverage of the annotated genomic feature by RNAseq alignments
ferric chelate reductase 1 like, transcript variant X1
ferric chelate reductase 1 like, transcript variant X2
DOMON domain-containing protein FRRS1L isoform X1
ferric chelate reductase 1 like, transcript variant X3
DOMON domain-containing protein FRRS1L isoform X2
transmembrane protein 245, transcript variant X1
transmembrane protein 245, transcript variant X2
elongator acetyltransferase complex subunit 1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: actin-like protein 7B
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins
transfer RNA glutamic acid (anticodon CUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized LOC122710184, transcript variant X2
uncharacterized LOC122710184, transcript variant X1
uncharacterized LOC122710123, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC122710123, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
transfer RNA glycine (anticodon CCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Kruppel like factor 4, transcript variant X1
Kruppel like factor 4, transcript variant X3
Kruppel like factor 4, transcript variant X2
transfer RNA histidin (anticodon GUG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
RAD23 homolog B, nucleotide excision repair protein
UV excision repair protein RAD23 homolog B
LOW QUALITY PROTEIN: zinc finger protein 462
COORDINATES: nucleotide motif:Rfam:12.0:RF00156
transmembrane protein 38B, transcript variant X1
transmembrane protein 38B, transcript variant X2
trimeric intracellular cation channel type B isoform X2
trimeric intracellular cation channel type B isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
T-cell acute lymphocytic leukemia protein 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
fibronectin type III and SPRY domain containing 1 like, transcript variant X3
fibronectin type III and SPRY domain containing 1 like, transcript variant X5
fibronectin type III and SPRY domain containing 1 like, transcript variant X2
fibronectin type III and SPRY domain containing 1 like, transcript variant X4
fibronectin type III and SPRY domain containing 1 like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
solute carrier family 44 member 1, transcript variant X3
choline transporter-like protein 1 isoform X3
solute carrier family 44 member 1, transcript variant X2
choline transporter-like protein 1 isoform X2
solute carrier family 44 member 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 4 ESTs, 10 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
choline transporter-like protein 1 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
ATP binding cassette subfamily A member 1, transcript variant X3
ATP binding cassette subfamily A member 1, transcript variant X6
ATP binding cassette subfamily A member 1, transcript variant X1
ATP binding cassette subfamily A member 1, transcript variant X5
ATP binding cassette subfamily A member 1, transcript variant X2
ATP binding cassette subfamily A member 1, transcript variant X7
ATP binding cassette subfamily A member 1, transcript variant X4
phospholipid-transporting ATPase ABCA1 isoform X2
phospholipid-transporting ATPase ABCA1 isoform X1
protein NipSnap homolog 3A, transcript variant X2
protein NipSnap homolog 3A, transcript variant X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 2 codons; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 2 codons; deleted 1 base in 1 codon; substituted 3 bases at 3 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: olfactory receptor 13D1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 EST, 40 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 57 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 67 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 69 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 mRNAs, 71 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 38 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 82 Proteins
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 70 Proteins
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; substituted 2 bases at 2 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: olfactory receptor 13C4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 12% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 22% coverage of the annotated genomic feature by RNAseq alignments
structural maintenance of chromosomes protein 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 80% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 558 ESTs, 31 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 3 Proteins, and 42% coverage of the annotated genomic feature by RNAseq alignments
glutamate ionotropic receptor NMDA type subunit 3A
protein phosphatase 3 regulatory subunit B, beta
ring finger protein 20, transcript variant X1
ring finger protein 20, transcript variant X2
uncharacterized LOC122710098, transcript variant X2
uncharacterized LOC122710098, transcript variant X5
uncharacterized LOC122710098, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
uncharacterized LOC122710098, transcript variant X4
uncharacterized LOC122710098, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
post-GPI attachment to proteins GalNAc transferase 4, transcript variant X5
post-GPI attachment to proteins GalNAc transferase 4, transcript variant X2
post-GPI attachment to proteins GalNAc transferase 4, transcript variant X4
post-GPI attachment to proteins GalNAc transferase 4, transcript variant X1
post-GPI attachment to proteins GalNAc transferase 4, transcript variant X3
post-GPI attachment to proteins GalNAc transferase 4, transcript variant X6
post-GPI attachment to proteins GalNAc transferase 4, transcript variant X7
post-GPI attachment to proteins factor 4
zinc finger protein 189, transcript variant X1
zinc finger protein 189, transcript variant X2
39S ribosomal protein L50, mitochondrial
acyl-coenzyme A amino acid N-acyltransferase 2-like, transcript variant X1
acyl-coenzyme A amino acid N-acyltransferase 2-like, transcript variant X2
acyl-coenzyme A amino acid N-acyltransferase 2-like
uncharacterized LOC122709949, transcript variant X1
uncharacterized LOC122709949, transcript variant X2
phospholipid phosphatase related 1, transcript variant X2
phospholipid phosphatase related 1, transcript variant X1
phospholipid phosphatase-related protein type 1
transfer RNA cysteine (anticodon ACA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transmembrane protein with EGF like and two follistatin like domains 1
Myb/SANT DNA binding domain containing 3, transcript variant X3
Myb/SANT DNA binding domain containing 3, transcript variant X1
Myb/SANT DNA binding domain containing 3, transcript variant X2
myb/SANT-like DNA-binding domain-containing protein 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins
cyclin dependent kinase 20, transcript variant X2
cyclin dependent kinase 20, transcript variant X4
cyclin dependent kinase 20, transcript variant X3
cyclin dependent kinase 20, transcript variant X1
cyclin dependent kinase 20, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
cyclin dependent kinase 20, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
cyclin dependent kinase 20, transcript variant X6
cyclin dependent kinase 20, transcript variant X8
transfer RNA serine (anticodon GCU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
cyclin dependent kinase 20, transcript variant X10
cyclin dependent kinase 20, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
mitochondrial import inner membrane translocase subunit Tim29-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 84% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: mitochondrial import inner membrane translocase subunit Tim29-like
jupiter microtubule associated homolog 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 ESTs, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 54 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
nucleoredoxin like 2, transcript variant X4
nucleoredoxin like 2, transcript variant X2
nucleoredoxin like 2, transcript variant X1
nucleoredoxin like 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 46% coverage of the annotated genomic feature by RNAseq alignments
SHC adaptor protein 3, transcript variant X2
SHC adaptor protein 3, transcript variant X3
SHC adaptor protein 3, transcript variant X1
CDC28 protein kinase regulatory subunit 2
cyclin-dependent kinases regulatory subunit 2
SECIS binding protein 2, transcript variant X1
SECIS binding protein 2, transcript variant X2
SECIS binding protein 2, transcript variant X3
SECIS binding protein 2, transcript variant X4
SECIS binding protein 2, transcript variant X8
SECIS binding protein 2, transcript variant X6
SECIS binding protein 2, transcript variant X9
SECIS binding protein 2, transcript variant X5
SECIS binding protein 2, transcript variant X7
selenocysteine insertion sequence-binding protein 2 isoform X1
selenocysteine insertion sequence-binding protein 2 isoform X2
selenocysteine insertion sequence-binding protein 2 isoform X3
selenocysteine insertion sequence-binding protein 2 isoform X4
selenocysteine insertion sequence-binding protein 2 isoform X8
selenocysteine insertion sequence-binding protein 2 isoform X6
selenocysteine insertion sequence-binding protein 2 isoform X9
selenocysteine insertion sequence-binding protein 2 isoform X5
selenocysteine insertion sequence-binding protein 2 isoform X7
uncharacterized LOC122672989, transcript variant X1
uncharacterized LOC122672989, transcript variant X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00568
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
growth arrest and DNA damage inducible gamma
growth arrest and DNA damage-inducible protein GADD45 gamma
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 27% coverage of the annotated genomic feature by RNAseq alignments
COORDINATES: nucleotide motif:Rfam:12.0:RF00548
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 90% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
spleen associated tyrosine kinase, transcript variant X1
spleen associated tyrosine kinase, transcript variant X3
spleen associated tyrosine kinase, transcript variant X2
AU RNA binding methylglutaconyl-CoA hydratase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
methylglutaconyl-CoA hydratase, mitochondrial isoform X2
AU RNA binding methylglutaconyl-CoA hydratase, transcript variant X4
AU RNA binding methylglutaconyl-CoA hydratase, transcript variant X3
AU RNA binding methylglutaconyl-CoA hydratase, transcript variant X1
methylglutaconyl-CoA hydratase, mitochondrial isoform X4
methylglutaconyl-CoA hydratase, mitochondrial isoform X3
methylglutaconyl-CoA hydratase, mitochondrial isoform X1
nuclear factor interleukin-3-regulated protein
receptor tyrosine kinase like orphan receptor 2, transcript variant X3
receptor tyrosine kinase like orphan receptor 2, transcript variant X1
receptor tyrosine kinase like orphan receptor 2, transcript variant X2
tyrosine-protein kinase transmembrane receptor ROR2 isoform X3
tyrosine-protein kinase transmembrane receptor ROR2 isoform X1
tyrosine-protein kinase transmembrane receptor ROR2 isoform X2
receptor tyrosine kinase like orphan receptor 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
tyrosine-protein kinase transmembrane receptor ROR2 isoform X4
serine palmitoyltransferase long chain base subunit 1
serine/threonine-protein kinase MRCK alpha-like
zinc finger protein 169, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
zinc finger protein 169, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
zinc finger protein 169, transcript variant X5
zinc finger protein 169, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
zinc finger protein 169, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
zinc finger protein 169, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
zinc finger protein 169, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
zinc finger protein 169, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
zinc finger protein 169, transcript variant X7
tripartite motif-containing protein 54-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 67% coverage of the annotated genomic feature by RNAseq alignments
protein tyrosine phosphatase domain containing 1, transcript variant X2
protein tyrosine phosphatase domain containing 1, transcript variant X1
protein tyrosine phosphatase domain containing 1, transcript variant X3
protein tyrosine phosphatase domain-containing protein 1 isoform X1
protein tyrosine phosphatase domain-containing protein 1 isoform X3
protein tyrosine phosphatase domain-containing protein 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins
PHD finger protein 2, transcript variant X2
PHD finger protein 2, transcript variant X1
PHD finger protein 2, transcript variant X3
lysine-specific demethylase PHF2 isoform X2
lysine-specific demethylase PHF2 isoform X1
lysine-specific demethylase PHF2 isoform X3
constitutive coactivator of PPAR-gamma-like protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, and 98% coverage of the annotated genomic feature by RNAseq alignments
WNK lysine deficient protein kinase 2, transcript variant X6
WNK lysine deficient protein kinase 2, transcript variant X5
WNK lysine deficient protein kinase 2, transcript variant X4
WNK lysine deficient protein kinase 2, transcript variant X3
WNK lysine deficient protein kinase 2, transcript variant X2
WNK lysine deficient protein kinase 2, transcript variant X1
serine/threonine-protein kinase WNK2 isoform X6
serine/threonine-protein kinase WNK2 isoform X5
serine/threonine-protein kinase WNK2 isoform X4
serine/threonine-protein kinase WNK2 isoform X3
serine/threonine-protein kinase WNK2 isoform X2
serine/threonine-protein kinase WNK2 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 mRNAs, 9 ESTs, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
caspase recruitment domain family member 19, transcript variant X2
caspase recruitment domain family member 19, transcript variant X1
caspase recruitment domain-containing protein 19 isoform X2
caspase recruitment domain-containing protein 19 isoform X1
COORDINATES: nucleotide motif:Rfam:12.0:RF00443
uncharacterized LOC122709996, transcript variant X2
uncharacterized LOC122709996, transcript variant X1
FYVE, RhoGEF and PH domain containing 3, transcript variant X4
FYVE, RhoGEF and PH domain containing 3, transcript variant X5
FYVE, RhoGEF and PH domain containing 3, transcript variant X2
FYVE, RhoGEF and PH domain containing 3, transcript variant X3
FYVE, RhoGEF and PH domain containing 3, transcript variant X1
FYVE, RhoGEF and PH domain-containing protein 3 isoform X2
FYVE, RhoGEF and PH domain-containing protein 3 isoform X3
FYVE, RhoGEF and PH domain-containing protein 3 isoform X1
BICD cargo adaptor 2, transcript variant X1
BICD cargo adaptor 2, transcript variant X2
small nucleolar RNA SNORA42/SNORA80 family
COORDINATES: nucleotide motif:Rfam:12.0:RF00406
inositol-pentakisphosphate 2-kinase, transcript variant X2
inositol-pentakisphosphate 2-kinase, transcript variant X3
inositol-pentakisphosphate 2-kinase, transcript variant X1
inositol-pentakisphosphate 2-kinase isoform X1
inositol-pentakisphosphate 2-kinase isoform X3
inositol-pentakisphosphate 2-kinase isoform X2
39S ribosomal protein L42, mitochondrial-like
extracellular matrix protein 2, transcript variant X1
extracellular matrix protein 2, transcript variant X2
extracellular matrix protein 2 isoform X1
extracellular matrix protein 2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
nucleolar protein 8, transcript variant X3
nucleolar protein 8, transcript variant X1
nucleolar protein 8, transcript variant X2
isoleucyl-tRNA synthetase 1, transcript variant X2
COORDINATES: nucleotide motif:Rfam:12.0:RF01229
isoleucyl-tRNA synthetase 1, transcript variant X1
isoleucine--tRNA ligase, cytoplasmic isoform X1
isoleucine--tRNA ligase, cytoplasmic isoform X2
isoleucyl-tRNA synthetase 1, transcript variant X3
isoleucine--tRNA ligase, cytoplasmic isoform X3
zinc finger protein 484, transcript variant X3
zinc finger protein 484, transcript variant X1
zinc finger protein 484, transcript variant X4
zinc finger protein 484, transcript variant X6
zinc finger protein 484, transcript variant X7
zinc finger protein 484, transcript variant X2
eukaryotic translation initiation factor 2 subunit 3-like
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: eukaryotic translation initiation factor 2 subunit 3-like
zinc finger protein 484, transcript variant X5
family with sequence similarity 240 member B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
family with sequence similarity 240 member B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
zinc finger protein 782, transcript variant X5
zinc finger protein 782, transcript variant X4
zinc finger protein 782, transcript variant X3
zinc finger protein 782, transcript variant X2
zinc finger protein 782, transcript variant X1
peroxiredoxin like 2C, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
peroxiredoxin like 2C, transcript variant X3
peroxiredoxin like 2C, transcript variant X1
cell division cycle 14B, transcript variant X11
cell division cycle 14B, transcript variant X8
cell division cycle 14B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 EST, 5 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
cell division cycle 14B, transcript variant X17
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 6 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
cell division cycle 14B, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
cell division cycle 14B, transcript variant X7
cell division cycle 14B, transcript variant X4
cell division cycle 14B, transcript variant X15
cell division cycle 14B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
cell division cycle 14B, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
cell division cycle 14B, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 EST, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
cell division cycle 14B, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
dual specificity protein phosphatase CDC14B isoform X15
dual specificity protein phosphatase CDC14B isoform X8
dual specificity protein phosphatase CDC14B isoform X4
dual specificity protein phosphatase CDC14B isoform X7
dual specificity protein phosphatase CDC14B isoform X13
dual specificity protein phosphatase CDC14B isoform X1
dual specificity protein phosphatase CDC14B isoform X2
dual specificity protein phosphatase CDC14B isoform X5
dual specificity protein phosphatase CDC14B isoform X9
dual specificity protein phosphatase CDC14B isoform X10
cell division cycle 14B, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
cell division cycle 14B, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
cell division cycle 14B, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 ESTs, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
cell division cycle 14B, transcript variant X16
cell division cycle 14B, transcript variant X14
dual specificity protein phosphatase CDC14B isoform X6
dual specificity protein phosphatase CDC14B isoform X12
dual specificity protein phosphatase CDC14B isoform X3
dual specificity protein phosphatase CDC14B isoform X14
dual specificity protein phosphatase CDC14B isoform X11
hyaluronan binding protein 4, transcript variant X2
hyaluronan binding protein 4, transcript variant X1
intracellular hyaluronan-binding protein 4 isoform X2
intracellular hyaluronan-binding protein 4 isoform X1
solute carrier family 35 member D2, transcript variant X3
solute carrier family 35 member D2, transcript variant X2
solute carrier family 35 member D2, transcript variant X1
UDP-N-acetylglucosamine/UDP-glucose/GDP-mannose transporter isoform X1
UDP-N-acetylglucosamine/UDP-glucose/GDP-mannose transporter isoform X2
UDP-N-acetylglucosamine/UDP-glucose/GDP-mannose transporter isoform X3
solute carrier family 35 member D2, transcript variant X4
UDP-N-acetylglucosamine/UDP-glucose/GDP-mannose transporter isoform X4
ERCC excision repair 6 like 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 ESTs, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
DNA excision repair protein ERCC-6-like 2 isoform X4
ERCC excision repair 6 like 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 ESTs, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
DNA excision repair protein ERCC-6-like 2 isoform X5
ERCC excision repair 6 like 2, transcript variant X2
ERCC excision repair 6 like 2, transcript variant X1
ERCC excision repair 6 like 2, transcript variant X3
DNA excision repair protein ERCC-6-like 2 isoform X1
DNA excision repair protein ERCC-6-like 2 isoform X2
DNA excision repair protein ERCC-6-like 2 isoform X3
uncharacterized LOC122710133, transcript variant X2
uncharacterized LOC122710133, transcript variant X1
uncharacterized LOC122710211, transcript variant X2
uncharacterized LOC122710211, transcript variant X1
uncharacterized LOC122673066, transcript variant X1
uncharacterized LOC122673066, transcript variant X2
FA complementation group C, transcript variant X1
FA complementation group C, transcript variant X3
FA complementation group C, transcript variant X4
FA complementation group C, transcript variant X2
FA complementation group C, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 40% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins
Fanconi anemia group C protein isoform X1
FA complementation group C, transcript variant X6
Fanconi anemia group C protein isoform X2
aminopeptidase O (putative), transcript variant X10
aminopeptidase O (putative), transcript variant X8
aminopeptidase O (putative), transcript variant X11
aminopeptidase O (putative), transcript variant X3
aminopeptidase O (putative), transcript variant X5
aminopeptidase O (putative), transcript variant X1
aminopeptidase O (putative), transcript variant X7
aminopeptidase O (putative), transcript variant X6
aminopeptidase O (putative), transcript variant X2
aminopeptidase O (putative), transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
aminopeptidase O (putative), transcript variant X4
aminopeptidase O (putative), transcript variant X13
aminopeptidase O (putative), transcript variant X12
aminopeptidase O (putative), transcript variant X15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
aminopeptidase O (putative), transcript variant X16
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
aminopeptidase O (putative), transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
death associated protein kinase 1, transcript variant X6
death associated protein kinase 1, transcript variant X1
death associated protein kinase 1, transcript variant X4
death associated protein kinase 1, transcript variant X3
death associated protein kinase 1, transcript variant X5
death associated protein kinase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 ESTs, 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
armadillo repeat-containing protein 1-like, transcript variant X1
armadillo repeat-containing protein 1-like isoform X1
armadillo repeat-containing protein 1-like, transcript variant X2
armadillo repeat-containing protein 1-like isoform X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 ESTs, 5 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: RNA-binding protein 7-like
uncharacterized LOC122710075, transcript variant X2
uncharacterized LOC122710075, transcript variant X3
uncharacterized LOC122710075, transcript variant X4
uncharacterized LOC122710075, transcript variant X5
uncharacterized LOC122710075, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
transfer RNA tryptophan (anticodon CCA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
yrdC domain-containing protein, mitochondrial-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 ESTs, 8 Proteins, and 77% coverage of the annotated genomic feature by RNAseq alignments
terminal uridylyl transferase 7, transcript variant X1
terminal uridylyl transferase 7, transcript variant X4
terminal uridylyl transferase 7, transcript variant X7
terminal uridylyl transferase 7, transcript variant X6
terminal uridylyl transferase 7, transcript variant X2
terminal uridylyl transferase 7, transcript variant X5
terminal uridylyl transferase 7, transcript variant X3
terminal uridylyltransferase 7 isoform X1
terminal uridylyltransferase 7 isoform X2
terminal uridylyltransferase 7 isoform X3
terminal uridylyltransferase 7 isoform X4
iron-sulfur cluster assembly 1, transcript variant X1
iron-sulfur cluster assembly 1, transcript variant X2
iron-sulfur cluster assembly 1 homolog, mitochondrial isoform X1
iron-sulfur cluster assembly 1 homolog, mitochondrial isoform X2
golgi membrane protein 1, transcript variant X4
golgi membrane protein 1, transcript variant X2
golgi membrane protein 1, transcript variant X1
golgi membrane protein 1, transcript variant X3
golgi membrane protein 1, transcript variant X5
N-alpha-acetyltransferase 35, NatC auxiliary subunit, transcript variant X1
N-alpha-acetyltransferase 35, NatC auxiliary subunit, transcript variant X4
N-alpha-acetyltransferase 35, NatC auxiliary subunit, transcript variant X2
N-alpha-acetyltransferase 35, NatC auxiliary subunit, transcript variant X3
N-alpha-acetyltransferase 35, NatC auxiliary subunit, transcript variant X5
N-alpha-acetyltransferase 35, NatC auxiliary subunit isoform X1
N-alpha-acetyltransferase 35, NatC auxiliary subunit isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 17 Proteins, and 83% coverage of the annotated genomic feature by RNAseq alignments
COORDINATES: nucleotide motif:Rfam:12.0:RF00015
ATP/GTP binding carboxypeptidase 1, transcript variant X1
ATP/GTP binding carboxypeptidase 1, transcript variant X2
ATP/GTP binding carboxypeptidase 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins
neurotrophic receptor tyrosine kinase 2, transcript variant X1
neurotrophic receptor tyrosine kinase 2, transcript variant X5
neurotrophic receptor tyrosine kinase 2, transcript variant X2
neurotrophic receptor tyrosine kinase 2, transcript variant X4
neurotrophic receptor tyrosine kinase 2, transcript variant X3
BDNF/NT-3 growth factors receptor isoform X2
BDNF/NT-3 growth factors receptor isoform X1
neurotrophic receptor tyrosine kinase 2, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 ESTs, 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
neurotrophic receptor tyrosine kinase 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 ESTs, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
BDNF/NT-3 growth factors receptor isoform X4
BDNF/NT-3 growth factors receptor isoform X3
neurotrophic receptor tyrosine kinase 2, transcript variant X8
BDNF/NT-3 growth factors receptor isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 1 EST, 15 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
small nucleolar RNA SNORA2/SNORA34 family
COORDINATES: nucleotide motif:Rfam:12.0:RF00410
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 14 ESTs, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins
RecQ mediated genome instability 1, transcript variant X2
RecQ mediated genome instability 1, transcript variant X1
recQ-mediated genome instability protein 1 isoform X2
recQ-mediated genome instability protein 1 isoform X1
heterogeneous nuclear ribonucleoprotein K, transcript variant X3
heterogeneous nuclear ribonucleoprotein K, transcript variant X6
heterogeneous nuclear ribonucleoprotein K, transcript variant X1
heterogeneous nuclear ribonucleoprotein K, transcript variant X5
heterogeneous nuclear ribonucleoprotein K, transcript variant X7
heterogeneous nuclear ribonucleoprotein K, transcript variant X2
heterogeneous nuclear ribonucleoprotein K, transcript variant X4
heterogeneous nuclear ribonucleoprotein K isoform X2
heterogeneous nuclear ribonucleoprotein K isoform X4
heterogeneous nuclear ribonucleoprotein K isoform X1
heterogeneous nuclear ribonucleoprotein K isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 59% coverage of the annotated genomic feature by RNAseq alignments
kinesin family member 27, transcript variant X4
kinesin family member 27, transcript variant X1
kinesin family member 27, transcript variant X6
kinesin family member 27, transcript variant X7
kinesin family member 27, transcript variant X2
kinesin family member 27, transcript variant X5
kinesin family member 27, transcript variant X8
kinesin family member 27, transcript variant X3
G kinase anchoring protein 1, transcript variant X1
G kinase anchoring protein 1, transcript variant X2
IDNK gluconokinase, transcript variant X1
IDNK gluconokinase, transcript variant X4
IDNK gluconokinase, transcript variant X5
IDNK gluconokinase, transcript variant X2
IDNK gluconokinase, transcript variant X3
FERM domain containing 3, transcript variant X1
FERM domain containing 3, transcript variant X2
FERM domain-containing protein 3 isoform X2
FERM domain-containing protein 3 isoform X1
mRNA cap guanine-N7 methyltransferase-like
FERM domain containing 3, transcript variant X3
FERM domain-containing protein 3 isoform X3
FERM domain containing 3, transcript variant X4
FERM domain-containing protein 3 isoform X4
LOW QUALITY PROTEIN: ras-related GTP-binding protein C-like
RAS and EF-hand domain containing, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 8 ESTs, 3 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
RAS and EF-hand domain containing, transcript variant X2
ras and EF-hand domain-containing protein isoform X1
ras and EF-hand domain-containing protein isoform X2
family with sequence similarity 205 member A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
family with sequence similarity 205 member A, transcript variant X3
family with sequence similarity 205 member A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
COORDINATES: nucleotide motif:Rfam:12.0:RF01210
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 20% coverage of the annotated genomic feature by RNAseq alignments
C-C motif chemokine ligand 19, transcript variant X2
C-C motif chemokine ligand 19, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 2 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
interleukin 11 receptor subunit alpha, transcript variant X2
interleukin 11 receptor subunit alpha, transcript variant X3
interleukin 11 receptor subunit alpha, transcript variant X1
interleukin-11 receptor subunit alpha isoform X2
interleukin-11 receptor subunit alpha isoform X1
galactose-1-phosphate uridylyltransferase, transcript variant X2
galactose-1-phosphate uridylyltransferase, transcript variant X1
galactose-1-phosphate uridylyltransferase isoform X2
galactose-1-phosphate uridylyltransferase isoform X1
sigma non-opioid intracellular receptor 1, transcript variant X2
sigma non-opioid intracellular receptor 1, transcript variant X1
sigma non-opioid intracellular receptor 1 isoform X1
sigma non-opioid intracellular receptor 1 isoform X2
AT-rich interaction domain 3C, transcript variant X1
AT-rich interaction domain 3C, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
AT-rich interactive domain-containing protein 3C isoform X1
AT-rich interactive domain-containing protein 3C isoform X2
dynactin subunit 3, transcript variant X1
dynactin subunit 3, transcript variant X2
ribonuclease P/MRP subunit p25 like, transcript variant X2
ribonuclease P/MRP subunit p25 like, transcript variant X1
ribonuclease P/MRP subunit p25 like, transcript variant X3
ribonuclease P/MRP subunit p25 like, transcript variant X4
ribonuclease P protein subunit p25-like protein
ciliary neurotrophic factor receptor, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
ciliary neurotrophic factor receptor, transcript variant X1
ciliary neurotrophic factor receptor, transcript variant X2
ciliary neurotrophic factor receptor, transcript variant X5
ciliary neurotrophic factor receptor, transcript variant X3
ciliary neurotrophic factor receptor, transcript variant X4
ciliary neurotrophic factor receptor subunit alpha isoform X1
ciliary neurotrophic factor receptor subunit alpha isoform X2
family with sequence similarity 219 member A, transcript variant X1
family with sequence similarity 219 member A, transcript variant X2
family with sequence similarity 219 member A, transcript variant X5
family with sequence similarity 219 member A, transcript variant X6
family with sequence similarity 219 member A, transcript variant X3
family with sequence similarity 219 member A, transcript variant X4
family with sequence similarity 219 member A, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 ESTs, 2 Proteins, and 90% coverage of the annotated genomic feature by RNAseq alignments
spermatid-specific manchette-related protein 1
myogenesis regulating glycosidase (putative)
nudix hydrolase 2, transcript variant X2
nudix hydrolase 2, transcript variant X11
nudix hydrolase 2, transcript variant X3
nudix hydrolase 2, transcript variant X6
nudix hydrolase 2, transcript variant X7
nudix hydrolase 2, transcript variant X5
nudix hydrolase 2, transcript variant X10
nudix hydrolase 2, transcript variant X1
nudix hydrolase 2, transcript variant X8
nudix hydrolase 2, transcript variant X9
nudix hydrolase 2, transcript variant X4
bis(5'-nucleosyl)-tetraphosphatase [asymmetrical]
kinesin family member 24, transcript variant X1
kinesin family member 24, transcript variant X3
kinesin family member 24, transcript variant X2
ubiquitin associated protein 1, transcript variant X1
ubiquitin associated protein 1, transcript variant X4
ubiquitin associated protein 1, transcript variant X2
ubiquitin associated protein 1, transcript variant X3
ubiquitin-associated protein 1 isoform X1
ubiquitin-associated protein 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
ubiquitin associated protein 2, transcript variant X2
ubiquitin associated protein 2, transcript variant X1
ubiquitin associated protein 2, transcript variant X6
ubiquitin associated protein 2, transcript variant X3
ubiquitin associated protein 2, transcript variant X4
ubiquitin associated protein 2, transcript variant X7
ubiquitin associated protein 2, transcript variant X5
ubiquitin-associated protein 2 isoform X1
ubiquitin-associated protein 2 isoform X2
ubiquitin-associated protein 2 isoform X3
ubiquitin-associated protein 2 isoform X4
ubiquitin-associated protein 2 isoform X5
ubiquitin-associated protein 2 isoform X6
ubiquitin associated protein 2, transcript variant X8
ubiquitin-associated protein 2 isoform X7
COORDINATES: nucleotide motif:Rfam:12.0:RF01191
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 mRNAs, 27 ESTs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
COORDINATES: nucleotide motif:Rfam:12.0:RF00012
thiosulfate sulfurtransferase/rhodanese-like domain-containing protein 3
nuclear transcription factor, X-box binding 1, transcript variant X2
nuclear transcription factor, X-box binding 1, transcript variant X1
transcriptional repressor NF-X1 isoform X2
transcriptional repressor NF-X1 isoform X1
BAG family molecular chaperone regulator 1
uncharacterized LOC122709952, transcript variant X1
uncharacterized LOC122709952, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
SMU1 DNA replication regulator and spliceosomal factor
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
DnaJ heat shock protein family (Hsp40) member A1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 45% coverage of the annotated genomic feature by RNAseq alignments
L-gulonolactone oxidase, transcript variant X1
L-gulonolactone oxidase, transcript variant X2
cholinergic receptor nicotinic alpha 2 subunit, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 2 ESTs, 25 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
neuronal acetylcholine receptor subunit alpha-2 isoform X1
cholinergic receptor nicotinic alpha 2 subunit, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 2 ESTs, 3 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
cholinergic receptor nicotinic alpha 2 subunit, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 2 ESTs, 4 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
neuronal acetylcholine receptor subunit alpha-2 isoform X2
neuronal acetylcholine receptor subunit alpha-2 isoform X3
cholinergic receptor nicotinic alpha 2 subunit, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 3 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
neuronal acetylcholine receptor subunit alpha-2 isoform X4
protein tyrosine kinase 2 beta, transcript variant X5
protein tyrosine kinase 2 beta, transcript variant X4
protein tyrosine kinase 2 beta, transcript variant X3
protein tyrosine kinase 2 beta, transcript variant X1
protein tyrosine kinase 2 beta, transcript variant X2
protein-tyrosine kinase 2-beta isoform X4
protein-tyrosine kinase 2-beta isoform X3
protein-tyrosine kinase 2-beta isoform X2
protein-tyrosine kinase 2-beta isoform X1
epidermal growth factor receptor substrate 15-like 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 88% coverage of the annotated genomic feature by RNAseq alignments
adrenoceptor alpha 1A, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 mRNAs, 46 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
adrenoceptor alpha 1A, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 mRNAs, 46 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
adrenoceptor alpha 1A, transcript variant X6
adrenoceptor alpha 1A, transcript variant X7
adrenoceptor alpha 1A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 mRNAs, 1 EST, 46 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
adrenoceptor alpha 1A, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 EST, 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
adrenoceptor alpha 1A, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 1 EST, 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
adrenoceptor alpha 1A, transcript variant X8
adrenoceptor alpha 1A, transcript variant X10
adrenoceptor alpha 1A, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 EST, 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
adrenoceptor alpha 1A, transcript variant X12
adrenoceptor alpha 1A, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 mRNAs, 46 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
adrenoceptor alpha 1A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 mRNAs, 46 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
BCL2 interacting protein 3 like, transcript variant X1
BCL2 interacting protein 3 like, transcript variant X2
BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like isoform X2
BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like isoform X1
protein phosphatase 2 regulatory subunit Balpha, transcript variant X3
protein phosphatase 2 regulatory subunit Balpha, transcript variant X2
protein phosphatase 2 regulatory subunit Balpha, transcript variant X1
protein phosphatase 2 regulatory subunit Balpha, transcript variant X4
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform isoform X3
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform isoform X2
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform isoform X1
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform isoform X4
transfer RNA cysteine (anticodon GCA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA leucine (anticodon AAG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
cell division cycle-associated protein 2
potassium channel tetramerization domain containing 9
dedicator of cytokinesis 5, transcript variant X1
dedicator of cytokinesis 5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 2 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
proline-rich protein 2-like, transcript variant X4
proline-rich protein 2-like, transcript variant X8
proline-rich protein 2-like, transcript variant X1
serine/arginine repetitive matrix protein 1-like isoform X1
proline-rich protein 2-like, transcript variant X6
proline-rich protein 2-like, transcript variant X5
proline-rich protein 2-like, transcript variant X9
proline-rich protein 2-like, transcript variant X7
proline-rich protein 2-like, transcript variant X10
proline-rich protein 2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
proline-rich protein 2-like, transcript variant X11
proline-rich protein 2-like, transcript variant X2
serine/arginine repetitive matrix protein 1-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 55% coverage of the annotated genomic feature by RNAseq alignments
disintegrin and metalloproteinase domain-containing protein 7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 1 Protein, and 97% coverage of the annotated genomic feature by RNAseq alignments
disintegrin and metalloproteinase domain-containing protein 28
uncharacterized LOC122710205, transcript variant X3
uncharacterized LOC122710205, transcript variant X2
uncharacterized LOC122710205, transcript variant X1
uncharacterized LOC122710205, transcript variant X4
solute carrier family 25 member 37, transcript variant X1
solute carrier family 25 member 37, transcript variant X2
solute carrier family 25 member 37, transcript variant X4
solute carrier family 25 member 37, transcript variant X3
ectonucleoside triphosphate diphosphohydrolase 4, transcript variant X4
ectonucleoside triphosphate diphosphohydrolase 4, transcript variant X2
ectonucleoside triphosphate diphosphohydrolase 4, transcript variant X1
ectonucleoside triphosphate diphosphohydrolase 4, transcript variant X5
ectonucleoside triphosphate diphosphohydrolase 4, transcript variant X3
ectonucleoside triphosphate diphosphohydrolase 4 isoform X1
ectonucleoside triphosphate diphosphohydrolase 4 isoform X2
R3H and coiled-coil domain-containing protein 1
tumor necrosis factor receptor superfamily member 10A-like, transcript variant X3
tumor necrosis factor receptor superfamily member 10A-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
tumor necrosis factor receptor superfamily member 10A-like, transcript variant X5
tumor necrosis factor receptor superfamily member 10A-like, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
tumor necrosis factor receptor superfamily member 10A-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
tumor necrosis factor receptor superfamily member 10A-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
tumor necrosis factor receptor superfamily member 10A-like, transcript variant X4
tumor necrosis factor receptor superfamily member 10A-like, transcript variant X7
tumor necrosis factor receptor superfamily member 10A-like, transcript variant X9
tumor necrosis factor receptor superfamily member 10A-like, transcript variant X11
tumor necrosis factor receptor superfamily member 10A-like, transcript variant X10
tumor necrosis factor receptor superfamily member 10A-like isoform X1
tumor necrosis factor receptor superfamily member 10A-like isoform X5
tumor necrosis factor receptor superfamily member 10A-like isoform X3
tumor necrosis factor receptor superfamily member 10A-like isoform X4
tumor necrosis factor receptor superfamily member 10A-like isoform X2
tumor necrosis factor receptor superfamily member 10A-like isoform X6
src substrate cortactin-like, transcript variant X8
src substrate cortactin-like, transcript variant X2
src substrate cortactin-like, transcript variant X12
src substrate cortactin-like, transcript variant X4
src substrate cortactin-like, transcript variant X3
src substrate cortactin-like, transcript variant X13
src substrate cortactin-like, transcript variant X5
src substrate cortactin-like, transcript variant X10
src substrate cortactin-like, transcript variant X15
src substrate cortactin-like, transcript variant X6
src substrate cortactin-like, transcript variant X16
src substrate cortactin-like, transcript variant X9
src substrate cortactin-like, transcript variant X7
src substrate cortactin-like, transcript variant X14
src substrate cortactin-like, transcript variant X11
src substrate cortactin-like, transcript variant X17
src substrate cortactin-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
uncharacterized LOC122672962, transcript variant X2
uncharacterized LOC122672962, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 ESTs, 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 ESTs, 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 ESTs, 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 ESTs, 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 ESTs, 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 ESTs, 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 ESTs, 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
tumor necrosis factor receptor superfamily member 10C-like isoform X3
tumor necrosis factor receptor superfamily member 10C-like isoform X2
tumor necrosis factor receptor superfamily member 10C-like isoform X1
tumor necrosis factor receptor superfamily member 10A-like isoform X7
translation initiation factor IF-2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
translation initiation factor IF-2-like isoform X1
translation initiation factor IF-2-like, transcript variant X2
translation initiation factor IF-2-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
tumor necrosis factor receptor superfamily member 10A-like, transcript variant X12
tumor necrosis factor receptor superfamily member 10A-like, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 92% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 89% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized protein LOC122710285 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized protein LOC122710285 isoform X1
uncharacterized protein LOC122710285 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 73% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
liprin-alpha-3-like, transcript variant X2
liprin-alpha-3-like, transcript variant X3
liprin-alpha-3-like, transcript variant X1
uncharacterized protein LOC122710281 isoform X7
uncharacterized protein LOC122710281 isoform X2
uncharacterized protein LOC122710281 isoform X1
uncharacterized protein LOC122710281 isoform X4
hematopoietic lineage cell-specific protein-like isoform X9
hematopoietic lineage cell-specific protein-like isoform X5
hematopoietic lineage cell-specific protein-like isoform X3
uncharacterized protein LOC122710281 isoform X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
tumor necrosis factor receptor superfamily member 10A-like, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
tumor necrosis factor receptor superfamily member 10A-like, transcript variant X17
tumor necrosis factor receptor superfamily member 10A-like, transcript variant X16
tumor necrosis factor receptor superfamily member 10A-like, transcript variant X15
liprin-alpha-1-like, transcript variant X2
liprin-alpha-1-like, transcript variant X1
uncharacterized LOC122672959, transcript variant X1
uncharacterized LOC122672959, transcript variant X4
uncharacterized LOC122672959, transcript variant X3
uncharacterized LOC122672959, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 ESTs, 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 ESTs, 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 ESTs, 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
tumor necrosis factor receptor superfamily member 10A-like, transcript variant X19
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
tumor necrosis factor receptor superfamily member 10A-like, transcript variant X18
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
uncharacterized protein LOC122710281 isoform X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 87% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized protein LOC122710284 isoform X2
uncharacterized protein LOC122710284 isoform X7
uncharacterized protein LOC122710284 isoform X1
uncharacterized protein LOC122710284 isoform X3
uncharacterized LOC122672960, transcript variant X2
uncharacterized LOC122672960, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
rho-related BTB domain-containing protein 2
phosphatidylethanolamine binding protein 4, transcript variant X2
phosphatidylethanolamine binding protein 4, transcript variant X3
phosphatidylethanolamine binding protein 4, transcript variant X1
phosphatidylethanolamine-binding protein 4
early growth response 3, transcript variant X2
early growth response protein 3 isoform X2
early growth response 3, transcript variant X3
early growth response 3, transcript variant X1
early growth response protein 3 isoform X1
early growth response protein 3 isoform X3
LOW QUALITY PROTEIN: cell cycle and apoptosis regulator protein 2
chromosome 16 C8orf58 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
chromosome 16 C8orf58 homolog, transcript variant X2
uncharacterized protein C8orf58 homolog isoform X1
uncharacterized protein C8orf58 homolog isoform X2
chromosome 16 C8orf58 homolog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; deleted 1 base in 1 codon; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: PDZ and LIM domain protein 2
sorbin and SH3 domain containing 3, transcript variant X8
sorbin and SH3 domain containing 3, transcript variant X3
sorbin and SH3 domain containing 3, transcript variant X6
sorbin and SH3 domain containing 3, transcript variant X2
sorbin and SH3 domain containing 3, transcript variant X5
sorbin and SH3 domain containing 3, transcript variant X1
sorbin and SH3 domain containing 3, transcript variant X4
sorbin and SH3 domain containing 3, transcript variant X7
sorbin and SH3 domain containing 3, transcript variant X9
protein phosphatase 3 catalytic subunit gamma, transcript variant X1
protein phosphatase 3 catalytic subunit gamma, transcript variant X3
protein phosphatase 3 catalytic subunit gamma, transcript variant X2
protein phosphatase 3 catalytic subunit gamma, transcript variant X4
serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform isoform X4
serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform isoform X2
serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform isoform X3
serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform isoform X1
solute carrier family 39 member 14, transcript variant X2
solute carrier family 39 member 14, transcript variant X3
solute carrier family 39 member 14, transcript variant X1
piwi like RNA-mediated gene silencing 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
piwi like RNA-mediated gene silencing 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
piwi like RNA-mediated gene silencing 2, transcript variant X1
RNA polymerase III subunit D, transcript variant X1
RNA polymerase III subunit D, transcript variant X2
DNA-directed RNA polymerase III subunit RPC4
transfer RNA arginine (anticodon CCU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
phytanoyl-CoA 2-hydroxylase interacting protein, transcript variant X1
phytanoyl-CoA 2-hydroxylase interacting protein, transcript variant X2
phytanoyl-CoA hydroxylase-interacting protein
bone morphogenetic protein 1, transcript variant X1
bone morphogenetic protein 1, transcript variant X2
pulmonary surfactant-associated protein C
receptor accessory protein 4, transcript variant X1
receptor accessory protein 4, transcript variant X2
receptor expression-enhancing protein 4 isoform X1
receptor expression-enhancing protein 4 isoform X2
HR upstream open reading frame, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
HR upstream open reading frame, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
HR lysine demethylase and nuclear receptor corepressor, transcript variant X2
HR lysine demethylase and nuclear receptor corepressor, transcript variant X1
lysine-specific demethylase hairless isoform X1
lysine-specific demethylase hairless isoform X2
FHF complex subunit HOOK interacting protein 2B, transcript variant X4
FHF complex subunit HOOK interacting protein 2B, transcript variant X3
FHF complex subunit HOOK interacting protein 2B, transcript variant X2
FHF complex subunit HOOK interacting protein 2B, transcript variant X1
FHF complex subunit HOOK interacting protein 2B, transcript variant X5
FHF complex subunit HOOK interacting protein 2B isoform X3
FHF complex subunit HOOK interacting protein 2B isoform X2
FHF complex subunit HOOK interacting protein 2B isoform X1
FHF complex subunit HOOK interacting protein 2B isoform X4
dematin actin binding protein, transcript variant X5
dematin actin binding protein, transcript variant X2
dematin actin binding protein, transcript variant X3
dematin actin binding protein, transcript variant X1
dematin actin binding protein, transcript variant X8
dematin actin binding protein, transcript variant X6
dematin actin binding protein, transcript variant X7
dematin actin binding protein, transcript variant X4
fibroblast growth factor 17, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 11 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
fibroblast growth factor 17, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 14 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
nucleophosmin/nucleoplasmin 2, transcript variant X4
nucleophosmin/nucleoplasmin 2, transcript variant X2
nucleophosmin/nucleoplasmin 2, transcript variant X1
nucleophosmin/nucleoplasmin 2, transcript variant X3
GDNF family receptor alpha 2, transcript variant X1
GDNF family receptor alpha 2, transcript variant X2
eukaryotic translation initiation factor 1-like
leucine zipper tumor suppressor 1, transcript variant X1
leucine zipper tumor suppressor 1, transcript variant X3
leucine zipper tumor suppressor 1, transcript variant X2
leucine zipper putative tumor suppressor 1
V-type proton ATPase subunit B, brain isoform
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 75% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 39% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122672974, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
uncharacterized LOC122672974, transcript variant X1
uncharacterized LOC122672974, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 17% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 11% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 39% coverage of the annotated genomic feature by RNAseq alignments
ankyrin repeat domain-containing protein 26-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 7 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 14% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 62% coverage of the annotated genomic feature by RNAseq alignments